CFI and age-related macular degeneration: Characterisation of novel genotypes adds to the growing list of dysfunctional CFI RVs, information which ultimately may help in the future clinical development strategies for complement inhibitors in AMD, and clinical diagnosis of other diseases associated with CFI RV mutations.